Characterization and consequences of pain variability in individuals with fibromyalgia.
Richard E Harris, David A Williams, Samuel A McLean...
https://pubmed.ncbi.nlm.nih.gov/16258905/Actively Recruiting
Led by Mardin Artuklu University · Updated on 2026-09-17
150
Participants Needed
1
Research Sites
N/A
Total Duration
This research aims to understand how daily changes in pain and fatigue relate to the impact on daily activities in adults diagnosed with fibromyalgia. The study focuses on symptom fluctuations rather than just average severity, recognizing that patients with similar average symptoms may experience different levels of difficulty. It includes adults aged 18 to 65 diagnosed according to the 2016 American College of Rheumatology criteria. Participants will attend an initial visit to complete clinical questionnaires covering functional impact, anxiety, depression, and central sensitization symptoms. Following this, they will record their pain and fatigue levels twice daily for seven days, along with daily sleep quality and perceived control over symptoms. No treatments or medical procedures are given during the study. During the study, participants symptom data will be analyzed to examine relationships between pain and fatigue fluctuations and functional impact while considering factors like age, sex, and disease duration. The study will also look at how sleep quality, maximum symptom levels, and perceived symptom control relate to functioning. These observations are collected through questionnaires and daily symptom records over a total seven-day monitoring period following the initial visit.
CONDITIONS
Daily Symptom Fluctuations and Functional Impact in Fibromyalgia
T
Taha Yasin YILDIRIM, M.D.
H
Hatice Gözde Sümer, M.D.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Mardin Artuklu University
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 7 days
Participants complete clinical questionnaires at the initial visit and then record their pain, fatigue, sleep quality, and perceived symptom control twice daily for seven days.
1 initial visit and daily symptom recording for 7 days
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Richard E Harris, David A Williams, Samuel A McLean...
https://pubmed.ncbi.nlm.nih.gov/16258905/Emily J Bartley, Michael E Robinson, Roland Staud
https://pubmed.ncbi.nlm.nih.gov/29253551/G Affleck, S Urrows, H Tennen...
https://pubmed.ncbi.nlm.nih.gov/9121825/Mardin Artuklu University
Lead Sponsor